MVCAX | MVCKX | MVCAX / MVCKX | |
Total Expense Ratio | 0.99 | 0.62 | 160% |
Annual Report Gross Expense Ratio | 1.00 | 0.63 | 159% |
Fund Existence | 24 years | 13 years | - |
Gain YTD | 0.750 | 0.944 | 79% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.8B | 16.8B | 100% |
Annual Yield % from dividends | 0.86 | 1.18 | 73% |
Returns for 1 year | -6.01 | -5.40 | 111% |
Returns for 3 years | 10.45 | 11.83 | 88% |
Returns for 5 years | 49.40 | 52.57 | 94% |
Returns for 10 years | 61.59 | 67.59 | 91% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FIAX | 18.23 | 0.11 | +0.61% |
Nicholas Fixed Income Alternative ETF | |||
THNR | 22.58 | 0.14 | +0.61% |
Amplify Weight Loss Drug & Treatment ETF | |||
FNDE | 33.21 | -0.18 | -0.54% |
Schwab Fundamental Emerging MarketsEqETF | |||
IGE | 44.55 | -0.53 | -1.18% |
iShares North American Natural Res ETF | |||
BDCX | 27.96 | -0.46 | -1.61% |
ETRACS Qrtly Py 1.5X Lvgd Wls Fg BDC ETN |